Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy
О. Ф. Гордеева
Seminars in Cancer Biology (2018) Vol. 53, pp. 75-89
Closed Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Cancer stem cells and niches: challenges in immunotherapy resistance
Yonglong Pan, Chaoyi Yuan, Chenglong Zeng, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell–Inflamed Phenotype
Taofeek K. Owonikoko, Bhakti Dwivedi, Zhengjia Chen, et al.
Journal of Thoracic Oncology (2020) Vol. 16, Iss. 3, pp. 464-476
Open Access | Times Cited: 133
CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma
Xiao-Lu Ma, Bo Hu, Wei-Guo Tang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 112
Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy
Afsheen Raza, Maysaloun Merhi, Varghese Inchakalody, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 82
Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies
Johannes P.W. Heidbuechel, Christine E. Engeland
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 77
The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity
Zhengguo Wu, Shang Li, Xiao Zhu
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 63
Cancer Vaccines: Antigen Selection Strategy
Yue Zhao, Alexey V. Baldin, Orkhan Isayev, et al.
Vaccines (2021) Vol. 9, Iss. 2, pp. 85-85
Open Access | Times Cited: 58
Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response
Wenbo Ning, Yan Sheng, Yingquan Song, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Cancer from the perspective of stem cells and misappropriated tissue regeneration mechanisms
Mariusz Z. Ratajczak, Kamila Bujko, Aaron Mack, et al.
Leukemia (2018) Vol. 32, Iss. 12, pp. 2519-2526
Open Access | Times Cited: 64
Role of long noncoding RNA-mediated competing endogenous RNA regulatory network in hepatocellular carcinoma
Zhao-Shan Niu, Wenhong Wang, Xianning Dong, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 29, pp. 4240-4260
Open Access | Times Cited: 58
Cancer/testis antigens: from serology to mRNA cancer vaccine
Chunmei Fan, Hongke Qu, Xu Wang, et al.
Seminars in Cancer Biology (2021) Vol. 76, pp. 218-231
Closed Access | Times Cited: 42
Long-read sequencing of an advanced cancer cohort resolves rearrangements, unravels haplotypes, and reveals methylation landscapes
Kieran O’Neill, Erin Pleasance, Jeremy Fan, et al.
Cell Genomics (2024) Vol. 4, Iss. 11, pp. 100674-100674
Open Access | Times Cited: 6
Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy
Yujie Zhang, Yuxin Zhang, Li Zhang
Journal of Cancer Research and Clinical Oncology (2019) Vol. 145, Iss. 2, pp. 281-291
Open Access | Times Cited: 50
Mesenchymal stem/stromal cells: Developmental origin, tumorigenesis and translational cancer therapeutics
Chenghai Li, Hua Zhao, Bin Wang
Translational Oncology (2020) Vol. 14, Iss. 1, pp. 100948-100948
Open Access | Times Cited: 44
The role of long non-coding RNA MIAT in cancers
Chao-Ming Da, Chao-Yang Gong, Wei Nan, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 129, pp. 110359-110359
Open Access | Times Cited: 43
Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
A. MacPherson, Simon C. Barry, Carmela Ricciardelli, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2967-2967
Open Access | Times Cited: 41
The biogenesis of the immunopeptidome
Arie Admon
Seminars in Immunology (2023) Vol. 67, pp. 101766-101766
Open Access | Times Cited: 15
Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review)
Shengnan Ren, Zhanyi Zhang, Mengyuan Li, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 6
Open Access | Times Cited: 14
The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination
Anliang Xia, Qi Yue, Mingming Zhu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 14
NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted cancer therapeutic route
Obed Boadi Amissah, Wenfang Chen, Jean de Dieu Habimana, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma
Jing Xu, Chengxiang Zhu, Yue Yu, et al.
EBioMedicine (2019) Vol. 46, pp. 54-65
Open Access | Times Cited: 38
How Tumor Cell Dedifferentiation Drives Immune Evasion and Resistance to Immunotherapy
Jinyang Li, Ben Z. Stanger
Cancer Research (2020) Vol. 80, Iss. 19, pp. 4037-4041
Open Access | Times Cited: 38
Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Kah Keng Wong, Rosline Hassan, Nik Soriani Yaacob
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 32
Small Non-Coding-RNA in Gynecological Malignancies
Shailendra Kumar Dhar Dwivedi, Geeta Rao, Anindya Dey, et al.
Cancers (2021) Vol. 13, Iss. 5, pp. 1085-1085
Open Access | Times Cited: 32
Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers
Huihan Ai, Hang Yang, Li Liang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top